Word

QI LU

Status

Registered

Status Code

700

Status Date

Tuesday, June 15, 2021

Serial Number

79282351

Registration Number

6382714

Registration Date

Tuesday, June 15, 2021

Mark Type

3000

Filing Date

Friday, December 27, 2019

Published for Opposition

Tuesday, March 30, 2021

Trademark Owner History

QILU PHARMACEUTICAL CO., LTD. - Original Registrant

Classifications

5 Medicines for the prevention and treatment of cancer, nervous system diseases, cardio-cerebrovascular disease, psychiatric disorders, ophthalmic diseases, andrology diseases, all for human purposes; Pharmaceutical preparations for the prevention and treatment of cancer, nervous system diseases, cardio-cerebrovascular disease, psychiatric disorders, ophthalmic diseases, andrology diseases, all for human purposes; Drugs for medical purposes for the prevention and treatment of cancer, nervous system diseases, cardio-cerebrovascular disease, psychiatric disorders, ophthalmic diseases, andrology diseases, all for human purposes; Ointments for pharmaceutical purposes for the prevention and treatment of cancer, nervous system diseases, cardio-cerebrovascular disease, psychiatric disorders, ophthalmic diseases, andrology diseases, all for human purposes; Crude drugs, namely, extracts of hops for pharmaceutical purposes, eucalyptus for pharmaceutical purposes, Mint for pharmaceutical purposes, Malt for pharmaceutical purposes, Pepsins for pharmaceutical purposes, Thymol for pharmaceutical purposes, Turpentine for pharmaceutical purposes, Flaxseed for pharmaceutical purposes, Ferments for pharmaceutical purposes, Cytostatics for pharmaceutical purposes, Balms for pharmaceutical purposes, Digestives for pharmaceutical purposes, Iodine for pharmaceutical purposes, Alcohol for pharmaceutical purposes, and Starch for pharmaceutical purposes, all for the prevention and treatment of cancer, nervous system diseases, cardio-cerebrovascular disease, psychiatric disorders, ophthalmic diseases, andrology diseases, all for human purposes; Cultures of microorganisms for medical or veterinary use; Nutritive substances for microorganisms for medical purposes; Veterinary preparations for pig, farm animals, companion animals, pets, ruminants, namely, vaccine, anti-parasite, antipyretic, analgesic, anti-inflammatory, antibiotic, disinfectants and feed additive preparations; Medicines for veterinary purposes for pig, farm animals, companion animals, pets, ruminants, namely, vaccine, anti-parasite, antipyretic, analgesic, anti-inflammatory, antibiotic, disinfectants and feed additive preparations; antibiotics

Color is not claimed as a feature of the mark.
"QI LU" AND THE NON-LATIN CHARACTERS THAT TRANSLITERATE TO "QI LU"
The mark consists of a stylized polygon shape with curved cutouts on its sides and down its middle, to the left of two Chinese characters which are above the stylized wording "QI LU".
The non-Latin characters in the mark transliterate to "QI LU" and this means "tidy" and "rash".
The English translation of "QI" and "LU" in the mark is "tidy" and "rash".

Trademark Events

Oct 29, 2021

Final Decision Transaction Processed By Ib

Sep 30, 2021

Final Disposition Notice Sent To Ib

Sep 29, 2021

Final Disposition Processed

Sep 15, 2021

Final Disposition Notice Created, To Be Sent To Ib

Jun 15, 2021

Registered-Principal Register

Mar 30, 2021

Official Gazette Publication Confirmation E-Mailed

Mar 30, 2021

Published For Opposition

Mar 28, 2021

Notification Processed By Ib

Mar 10, 2021

Notification Of Possible Opposition Sent To Ib

Mar 10, 2021

Notice Of Start Of Opposition Period Created, To Be Sent To Ib

Mar 10, 2021

Notification Of Notice Of Publication E-Mailed

Feb 22, 2021

Approved For Pub - Principal Register

Feb 22, 2021

Examiner's Amendment Entered

Feb 22, 2021

Notification Of Examiners Amendment E-Mailed

Feb 22, 2021

Examiners Amendment E-Mailed

Feb 22, 2021

Examiners Amendment -Written

Feb 17, 2021

Previous Allowance Count Withdrawn

Feb 16, 2021

Withdrawn From Pub - Og Review Query

Feb 3, 2021

Approved For Pub - Principal Register

Feb 3, 2021

Examiner's Amendment Entered

Feb 3, 2021

Notification Of Examiners Amendment E-Mailed

Feb 3, 2021

Examiners Amendment E-Mailed

Feb 3, 2021

Examiners Amendment -Written

Feb 2, 2021

Teas/Email Correspondence Entered

Feb 2, 2021

Correspondence Received In Law Office

Feb 1, 2021

Assigned To Lie

Oct 23, 2020

Teas Response To Office Action Received

May 15, 2020

Refusal Processed By Ib

Apr 28, 2020

Non-Final Action Mailed - Refusal Sent To Ib

Apr 28, 2020

Refusal Processed By Mpu

Apr 10, 2020

Non-Final Action (Ib Refusal) Prepared For Review

Apr 9, 2020

Non-Final Action Written

Apr 7, 2020

Application Filing Receipt Mailed

Apr 3, 2020

Assigned To Examiner

Apr 3, 2020

New Application Office Supplied Data Entered In Tram

Apr 2, 2020

Sn Assigned For Sect 66a Appl From Ib